First Time Loading...

CHC Healthcare Group
TWSE:4164

Watchlist Manager
CHC Healthcare Group Logo
CHC Healthcare Group
TWSE:4164
Watchlist
Price: 52.3 TWD 0.19% Market Closed
Updated: May 15, 2024

Profitability Summary

51/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

Past Growth

To be successful and remain in business, both growth and profitability are important and necessary. Net Income growth is often seen as a sign of a company's efficiency from an operational standpoint, but is influenced heavily by a company's goals and challenges and should therefore be assessed in conjunction with other metrics like revenue and operating income growth.

Margins

Profit margins represent what percentage of sales has turned into profits. Simply put, the percentage figure indicates how many cents of profit the company has generated for each dollar of sale.

Profit margins help investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Earnings Waterfall
CHC Healthcare Group

Revenue
3.7B TWD
Cost of Revenue
-2.7B TWD
Gross Profit
984.8m TWD
Operating Expenses
-467.8m TWD
Operating Income
517m TWD
Other Expenses
-175.1m TWD
Net Income
341.9m TWD

Margins Comparison
CHC Healthcare Group Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
TW
CHC Healthcare Group
TWSE:4164
8.7B TWD
26%
14%
9%
US
Mckesson Corp
NYSE:MCK
71.7B USD
4%
1%
1%
US
Cencora Inc
NYSE:COR
44.3B USD
3%
1%
1%
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD
3%
1%
1%
US
Cardinal Health Inc
NYSE:CAH
23.8B USD
3%
1%
0%
US
Henry Schein Inc
NASDAQ:HSIC
9.3B USD
31%
5%
3%
CN
Sinopharm Group Co Ltd
HKEX:1099
70.4B HKD
8%
4%
2%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
30%
9%
7%
CN
Huadong Medicine Co Ltd
SZSE:000963
58.8B CNY
32%
9%
7%
IT
Amplifon SpA
MIL:AMP
7.7B EUR
65%
12%
7%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
53.7B CNY
12%
3%
1%
Country TW
Market Cap 8.7B TWD
Gross Margin
26%
Operating Margin
14%
Net Margin
9%
Country US
Market Cap 71.7B USD
Gross Margin
4%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 44.3B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 35.4B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
1%
Country US
Market Cap 23.8B USD
Gross Margin
3%
Operating Margin
1%
Net Margin
0%
Country US
Market Cap 9.3B USD
Gross Margin
31%
Operating Margin
5%
Net Margin
3%
Country CN
Market Cap 70.4B HKD
Gross Margin
8%
Operating Margin
4%
Net Margin
2%
Country KR
Market Cap 12.2T KRW
Gross Margin
30%
Operating Margin
9%
Net Margin
7%
Country CN
Market Cap 58.8B CNY
Gross Margin
32%
Operating Margin
9%
Net Margin
7%
Country IT
Market Cap 7.7B EUR
Gross Margin
65%
Operating Margin
12%
Net Margin
7%
Country CN
Market Cap 53.7B CNY
Gross Margin
12%
Operating Margin
3%
Net Margin
1%

Return on Capital

Return on capital ratios give a sense of how well a company is using its capital (equity, assets, capital employed, etc.) to generate profits (operating income, net income, etc.). In simple words, these ratios show how much income is generated for each dollar of capital invested.

Return on Capital Comparison
CHC Healthcare Group Competitors

Country Company Market Cap ROE ROA ROCE ROIC
TW
CHC Healthcare Group
TWSE:4164
8.7B TWD
6%
3%
4%
3%
US
Mckesson Corp
NYSE:MCK
71.7B USD
-157%
5%
27%
21%
US
Cencora Inc
NYSE:COR
44.3B USD
272%
3%
20%
15%
US
Amerisourcebergen Corp
NYSE:ABC
35.4B USD
371%
3%
18%
13%
US
Cardinal Health Inc
NYSE:CAH
23.8B USD
-20%
1%
21%
13%
US
Henry Schein Inc
NASDAQ:HSIC
9.3B USD
11%
4%
9%
6%
CN
Sinopharm Group Co Ltd
HKEX:1099
70.4B HKD
13%
2%
18%
8%
KR
Celltrion Healthcare Co Ltd
KOSDAQ:091990
12.2T KRW
7%
3%
9%
5%
CN
Huadong Medicine Co Ltd
SZSE:000963
58.8B CNY
15%
9%
17%
13%
IT
Amplifon SpA
MIL:AMP
7.7B EUR
15%
4%
11%
7%
CN
Shanghai Pharmaceuticals Holding Co Ltd
SSE:601607
53.7B CNY
6%
2%
10%
5%
Country TW
Market Cap 8.7B TWD
ROE
6%
ROA
3%
ROCE
4%
ROIC
3%
Country US
Market Cap 71.7B USD
ROE
-157%
ROA
5%
ROCE
27%
ROIC
21%
Country US
Market Cap 44.3B USD
ROE
272%
ROA
3%
ROCE
20%
ROIC
15%
Country US
Market Cap 35.4B USD
ROE
371%
ROA
3%
ROCE
18%
ROIC
13%
Country US
Market Cap 23.8B USD
ROE
-20%
ROA
1%
ROCE
21%
ROIC
13%
Country US
Market Cap 9.3B USD
ROE
11%
ROA
4%
ROCE
9%
ROIC
6%
Country CN
Market Cap 70.4B HKD
ROE
13%
ROA
2%
ROCE
18%
ROIC
8%
Country KR
Market Cap 12.2T KRW
ROE
7%
ROA
3%
ROCE
9%
ROIC
5%
Country CN
Market Cap 58.8B CNY
ROE
15%
ROA
9%
ROCE
17%
ROIC
13%
Country IT
Market Cap 7.7B EUR
ROE
15%
ROA
4%
ROCE
11%
ROIC
7%
Country CN
Market Cap 53.7B CNY
ROE
6%
ROA
2%
ROCE
10%
ROIC
5%

Free Cash Flow

Free cash flow (FCF) is the money a company has left over after paying its operating expenses and capital expenditures. The more free cash flow a company has, the more it can allocate to dividends, paying down debt, and growth opportunities.

If a company has a decreasing free cash flow, that is not necessarily bad if the company is investing in its growth.

See Also

Discover More